FDG PET/CT in the post-treatment evaluation of breast cancer: an emphasis on triple-negative breast cancer
American Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.62347/anso2768 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Shreeya H Gandhi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hospital of The University of Pennsylvania 3400 Spruce Street, Philadelphia, PA 19104, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Hospital of The University of Pennsylvania 3400 Spruce Street, Philadelphia, PA 19104, USA.
- Department of Radiology and Biomedical Imaging, Yale New Haven Hospital New Haven, CT 06520, USA.
- The Intervention Center, Division for Technology and Innovation, Oslo University Hospital Sognsvannsveien 20, 0372 Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo Klaus Torgårds Vei 3, 0372 Oslo, Norway.
Zitieren
APA
Gandhi, S. H., Gujral, J., Amanullah, A. A., Gandhi, O. H., Singh, S. B., Werner, T. J., Revheim, M. E., & Alavi, A. (2026). FDG PET/CT in the post-treatment evaluation of breast cancer: an emphasis on triple-negative breast cancer. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/anso2768
Vancouver
Gandhi SH, Gujral J, Amanullah AA, Gandhi OH, Singh SB, Werner TJ, et al. FDG PET/CT in the post-treatment evaluation of breast cancer: an emphasis on triple-negative breast cancer. American Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.62347/anso2768
BibTeX
@article{Gandhi2026,
author = {Gandhi, Shreeya H and Gujral, Jaskeerat and Amanullah, Amir A and Gandhi, Om H and Singh, Shashi B and Werner, Thomas J and Revheim, Mona-Elisabeth and Alavi, Abass},
title = {FDG PET/CT in the post-treatment evaluation of breast cancer: an emphasis on triple-negative breast cancer},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.62347/anso2768}
}
EUVIMED